Trial intelligence / Profile preview

Pregabalin (Lyrica) monotherapy in partial seizures

2009-016849-25Phase 3Terminated

Sponsor
Pfizer
Start
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of pregabalin in Focal onset seizure and epilepsy, sponsored by Pfizer. Started Jan 2010; status: terminated.

02

Drugs

pregabalin
03

Conditions

Focal onset seizureepilepsy

Beyond the preview

Go deeper on 2009-016849-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016849-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call